Today: 8 February 2026
Subscribe
Browse Category

Stock Market News 30 December 2025

Arcutis Biotherapeutics stock slides today as biotech pulls back, ARQT down nearly 3%

Arcutis Biotherapeutics stock slides today as biotech pulls back, ARQT down nearly 3%

NEW YORK, December 30, 2025, 14:45 ET — Regular session Arcutis Biotherapeutics shares fell 2.9% to $27.74 in afternoon trading on Tuesday, after moving between $27.72 and $28.65. Volume was about 0.6 million shares. The drop outpaced broader biotech gauges, with the SPDR S&P Biotech ETF down about 1.5% and the iShares Nasdaq Biotechnology ETF off about 1.1%. That matters for Arcutis because it trades as a growth story tied to one product franchise, leaving the stock prone to outsized moves when sentiment sours across biotech and high-multiple names. Arcutis is a commercial-stage medical dermatology company whose main product, Zoryve
30 December 2025
·
Rigetti stock today: RGTI steadies as Fed minutes and year-end flows keep quantum names jumpy

Rigetti stock today: RGTI steadies as Fed minutes and year-end flows keep quantum names jumpy

Rigetti Computing shares rose 0.3% to $22.34 Tuesday afternoon after swinging 3% intraday. IonQ gained 1.2% and D-Wave Quantum advanced 1.6%, while the broader market was flat. Trading was thin ahead of year-end, with investors rotating within technology. The Federal Reserve’s December minutes showed policymakers split on further rate cuts.
30 December 2025
·····
Ares Management stock drops 3% in New York as Fed minutes hit year-end trading

Ares Management stock drops 3% in New York as Fed minutes hit year-end trading

Ares Management shares dropped 3.1% to $163.85 Tuesday afternoon, underperforming rivals as fresh Federal Reserve minutes showed policymakers split on future rate cuts. A Reuters column noted shrinking yield premiums in private credit, a core Ares business, as public markets regain ground. About 966,000 Ares shares traded, with the stock hitting a low of $163.49. Blackstone was flat; Apollo, KKR, and Carlyle edged down less than 1%.
30 December 2025
··
AT&T stock today ticks higher as Fed minutes loom and year-end rotation lifts telecoms

AT&T stock today ticks higher as Fed minutes loom and year-end rotation lifts telecoms

AT&T shares rose 0.1% to $24.80 Tuesday afternoon as the broader market remained subdued ahead of Federal Reserve minutes. The stock traded in a narrow range, with peers Verizon and T-Mobile also slightly higher. Investors are watching for AT&T’s Jan. 28 earnings and updates on satellite connectivity with AST SpaceMobile. The 10-year Treasury yield edged up to 4.134%.
30 December 2025
·····
Freeport-McMoRan stock today: FCX edges up as copper rebounds toward record highs

Freeport-McMoRan stock today: FCX edges up as copper rebounds toward record highs

NEW YORK, December 30, 2025, 2:22 PM ET — Regular session Freeport-McMoRan shares rose about 0.5% to $51.75 in afternoon trading on Tuesday, after swinging between $50.87 and $52.67 earlier in the session. The move matters because Freeport’s earnings tend to track copper prices closely. When the metal rises, miners typically see higher revenue per pound sold, which can lift cash generation. Copper’s year-end rally has put the spotlight back on supply tightness and demand tied to electrification and the buildout of power-hungry data centers. That backdrop has helped keep interest in large, liquid copper names such as Freeport. U.S.
30 December 2025
··
Why Karman Holdings Stock Is Down Today: KRMN Slides as Year-End Flows Hit Defense-Space Names

Why Karman Holdings Stock Is Down Today: KRMN Slides as Year-End Flows Hit Defense-Space Names

Karman Holdings shares fell 3.6% to $74.81 in New York afternoon trading Tuesday, underperforming the broader market after a $258.7 million outflow from the SPDR S&P Aerospace & Defense ETF. The stock touched a session low of $74.21, with about 465,000 shares traded. Investors are watching for signs of stabilization ahead of the company’s next quarterly update.
30 December 2025
··
CRH stock dips today as buyback rolls on and Fed minutes loom

CRH stock dips today as buyback rolls on and Fed minutes loom

CRH shares fell 1.1% to $126.01 in New York Tuesday after the company disclosed buying 31,100 shares Monday under its U.S. buyback program. The repurchases, part of a $300 million plan, came as markets traded in thin year-end conditions. Investors awaited Federal Reserve minutes due later in the day. Other U.S.-listed aggregates producers also slipped.
30 December 2025
·
Schwab stock slips as Fed minutes put rate outlook back in focus

Schwab stock slips as Fed minutes put rate outlook back in focus

Charles Schwab shares fell 0.6% to $100.69 in afternoon trading Tuesday, with rivals Interactive Brokers and Robinhood also lower. Investors awaited Federal Reserve minutes due later in the day for signals on rate policy. A regulatory filing showed Schwab executive Jonathan Beatty exercised options and a related trust sold 2,000 shares at about $102.01. Schwab’s fourth-quarter results are expected Jan. 21.
30 December 2025
·····
KLA stock dips as China’s 50% domestic chip-tool rule rattles semiconductor equipment names

KLA stock dips as China’s 50% domestic chip-tool rule rattles semiconductor equipment names

KLA shares fell 0.8% to $1,250.43 Tuesday after a Reuters report said China will require chipmakers to source at least half of new-fab equipment domestically. U.S. chip-equipment stocks tracked lower as traders awaited Federal Reserve minutes and eyed tightening export-license rules. Applied Materials and Lam Research also declined, while ASML rose.
30 December 2025
······
Arrowhead Pharmaceuticals stock slides today as biotech dips; ARWR investors eye January obesity data

Arrowhead Pharmaceuticals stock slides today as biotech dips; ARWR investors eye January obesity data

Arrowhead Pharmaceuticals shares fell 3.6% to $67.09 by early afternoon Tuesday, outpacing declines in biotech peers as traders positioned ahead of key January updates. The drop followed recent volatility after FDA approval of REDEMPLO, the company’s first commercial drug for familial chylomicronemia syndrome. Arrowhead plans to release interim obesity-program data and present at the J.P. Morgan Healthcare Conference in early January.
30 December 2025
··
Wells Fargo stock slips as Fed minutes loom in thin year-end trading

Wells Fargo stock slips as Fed minutes loom in thin year-end trading

Wells Fargo shares fell 0.4% to $94.15 in afternoon New York trading Tuesday, tracking declines across U.S. bank stocks ahead of Federal Reserve meeting minutes. Investors focused on rate expectations for 2026 and the bank’s upcoming earnings in mid-January. The 10-year Treasury yield rose to 4.134% as financial sector ETFs also slipped in thin, year-end trading.
30 December 2025
···
Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook

Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook

Pfizer shares edged up 0.1% to $25.03 Tuesday after TD Cowen reiterated a Hold rating and $30 price target, citing negative trends through 2030. The company projected 2026 revenue of $59.5 billion to $62.5 billion and warned of a “bumpy” period ahead as COVID demand fades and key patents expire. Shares have dropped over 50% since early 2023. Pfizer’s next earnings report is set for February 3.
30 December 2025
··
1 … 562 563 564 565 566 … 1,177

Stock Market Today

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Go toTop